Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Extra Bone Resorption in Pregnancy, Lactation May Pass Maternal Lead Burden to Baby

Reuters Staff  |  June 7, 2016

NEW YORK (Reuters Health)—Bone resorption increases during pregnancy and continues to be high postpartum, according to new findings using lead testing to measure bone turnover.

Researchers also found unexpected evidence that maternal lead burden is transferred to the fetus.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“These data confirm calcium balance studies that indicate increased bone resorption throughout pregnancy and lactation,” Dr. Brian Gulson of Macquarie University in Sydney, Australia, and colleagues write in Bone, online May 24. “They also indicate potentially major public health implications of the transfer of maternal Pb burden to the fetus and newborn.”

Analyzing bone formation and absorption with standard biomarkers, such as osteocalcin, gives divergent results in pregnant and postpartum women, the team notes.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Concentrations of lead and lead isotopic tracing offer an alternative way to assess bone turnover that is not affected by metabolism or hemodilution, the researchers add. Studies using this technique have shown that lead is mobilized from the skeleton during pregnancy and lactation, as well as extended bed rest and weightlessness.

The Australian environment has a unique isotopic fingerprint due to the presence of ancient lead (about 1.7 million years old), the researchers write, so it is possible to gauge pregnancy-related shifts in lead in recent immigrants. They monitored changes in blood concentrations and isotopic ratio monthly in two cohorts of immigrants and a control group of six Australian women. One cohort (n=10) received calcium supplements, one did not (n=15).

In the second trimester, blood lead decreased, and then increased during the third trimester, suggesting increased mobilization of lead from the skeleton. Lead levels continued to rise after the women gave birth, independent of how long they breastfed their infants, their diet or when their menses resumed.

Unexpectedly, three women in the control group had isotope ratio changes indicative of exposure to European lead. All of their mothers had come from Europe, suggesting that lead may have been transmitted to the daughters during pregnancy and lactation.

“These data are consistent with multi-generational passage of lead and potential effects on DNA methylation with its known effects on biology and biological versus chronological age,” Dr. Gulson and his team write. “Further evidence for these processes could be obtained from the children of the cohorts.”

They conclude: “The significance of these findings in mothers with high skeletal Pb burdens in relation to fetal and neonatal Pb exposure needs further consideration and study.”

Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:boneleadpregnancy

Related Articles

    The Chimeric Self

    February 1, 2007

    Michrochimerism research offers insights into several autoimmune conditions

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences